Mycophenolic acid differentially affects dendritic cell maturation induced by tumor necrosis factor-α and lipopolysaccharide through a different modulation of MAPK signaling

Molecular Immunology

Volumn 47, Issue 9, 2010, Pages 1848-1859

  Faugaret, Delphine ^a   Lemoine, Roxane ^a   Baron, Christophe ^a,b   Lebranchu, Yvon ^a,b   Velge Roussel, Florence ^a,c  

^a FHU SUPORT   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c UFR des Sciences Pharmaceutiques   (France)

Author keywords

Dendritic cells; MAPK signaling; Mycophenolic acid

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GUANOSINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYCOPHENOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MICROENVIRONMENT; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYCOPHENOLIC ACID; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952322370     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.10.026     Document Type: Article

References (68)

1. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003, 171:4984-4989.
2. Aiba S., Manome H., Nakagawa S., Mollah Z.U., Mizuashi M., Ohtani T., Yoshino Y., Tagami H. p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens. NiCl2 and 2,4-dinitrochlorobenzene. J. Invest. Dermatol. 2003, 120:390-399.
3. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
4. Alegre M.L., Florquin S., Goldman M. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr. Opin. Immunol. 2007, 19:563-568.
5. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 2000, 47:85-118.
6. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
7. Arimilli S., Johnson J.B., Alexander-Miller M.A., Parks G.D. TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways. Virology 2007, 365:144-156.
8. Arrighi J.F., Rebsamen M., Rousset F., Kindler V., Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide. TNF-alpha, and contact sensitizers. J. Immunol. 2001, 166:3837-3845.
9. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
10. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
11. Boggiatto P.M., Jie F., Ghosh M., Gibson-Corley K.N., Ramer-Tait A.E., Jones D.E., Petersen C.A. Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase. ERK Am. J. Pathol. 2009, 174:1818-1826.
12. Bradley J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214:149-160.
13. Buckland M., Lombardi G. Aspirin and the induction of tolerance by dendritic cells. Handb. Exp. Pharmacol. 2009, 197-213.
14. Bunyard P., Handley M., Pollara G., Rutault K., Wood I., Chaudry M., Alderman C., Foreman J., Katz D.R., Chain B.M. Ribotoxic stress activates p38 and JNK kinases and modulates the antigen-presenting activity of dendritic cells. Mol. Immunol. 2003, 39:815-827.
15. Chandra D., Naik S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin. Exp. Immunol. 2008, 154:224-234.
16. Chen L., Wang T., Zhou P., Ma L., Yin D., Shen J., Molinero L., Nozaki T., Phillips T., Uematsu S., Akira S., Wang C.R., Fairchild R.L., Alegre M.L., Chong A. TLR engagement prevents transplantation tolerance. Am. J. Transplant 2006, 6:2282-2291.
17. - T cells to acquire regulatory cell function. Blood 2003, 101:5076-5083.
18. Chow S., Hedley D., Grom P., Magari R., Jacobberger J.W., Shankey T.V. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations. Cytometry A 2005, 67:4-17.
19. Colic M., Stojic-Vukanic Z., Pavlovic B., Jandric D., Stefanoska I. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin. Exp. Immunol. 2003, 134:63-69.
20. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
21. Cui H., Matsui K., Omura S., Schauer S.L., Matulka R.A., Sonenshein G.E., Ju S.T. Proteasome regulation of activation-induced T cell death. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7515-7520.
22. Dick L.R., Cruikshank A.A., Grenier L., Melandri F.D., Nunes S.L., Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J. Biol. Chem. 1996, 271:7273-7276.
23. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., Kasprowicz D.J., Kellar K., Pare J., van Dyke T., Ziegler S., Unutmaz D., Pulendran B. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 2006, 116:916-928.
24. Dubsky P.C., Friedl J., Stift A., Bachleitner-Hofmann T., Jakesz R., Gnant M.F., Weigel G. Inosine 5′-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells. Clin. Chim. Acta 2006, 364:139-147.
25. Figueiredo A.S., Hofer T., Klotz C., Sers C., Hartmann S., Lucius R., Hammerstein P. Modelling and simulating interleukin-10 production and regulation by macrophages after stimulation with an immunomodulator of parasitic nematodes. FEBS J. 2009.
26. Fricke I., Mitchell D., Mittelstadt J., Lehan N., Heine H., Goldmann T., Bohle A., Brandau S. Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2. J. Immunol. 2006, 176:5173-5182.
27. Fukao T., Matsuda S., Koyasu S. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J. Immunol. 2000, 164:64-71.
28. Fulton B., Markham A. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 1996, 51:278-298.
29. Granucci F., Vizzardelli C., Pavelka N., Feau S., Persico M., Virzi E., Rescigno M., Moro G., Ricciardi-Castagnoli P. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2001, 2:882-888.
30. Ha H., Kim M.S., Park J., Huh J.Y., Huh K.H., Ahn H.J., Kim Y.S. Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition. Life Sci. 2006, 79:1561-1567.
31. Hackstein H., Thomson A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004, 4:24-34.
32. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001, 194:769-779.
33. Hoarau C., Lagaraine C., Martin L., Velge-Roussel F., Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 2006, 117:696-702.
34. Hoarau C., Martin L., Faugaret D., Baron C., Dauba A., Aubert-Jacquin C., Velge-Roussel F., Lebranchu Y. Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS ONE 2008, 3:e2753.
35. Kalinski P., Smits H.H., Schuitemaker J.H., Vieira P.L., van Eijk M., de Jong E.C., Wierenga E.A., Kapsenberg M.L. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J. Immunol. 2000, 165:1877-1881.
36. Kamath N.S., John G.T., Neelakantan N., Kirubakaran M.G., Jacob C.K. Acute graft pyelonephritis following renal transplantation. Transpl. Infect. Dis. 2006, 8:140-147.
37. Kawai T., Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 2007, 13:460-469.
38. Kumar S., McDonnell P.C., Gum R.J., Hand A.T., Lee J.C., Young P.R. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 1997, 235:533-538.
39. Lagaraine C., Hoarau C., Chabot V., Velge-Roussel F., Lebranchu Y. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int. Immunol. 2005, 17:351-363.
40. + regulatory T cells by mycophenolic acid-treated dendritic cells. J. Leukoc. Biol. 2008, 84:1057-1064.
41. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
42. Luo X., Liu L., Tang N., Lu K.Q., McCormick T.S., Kang K., Cooper K.D. Inhibition of monocyte-derived dendritic cell differentiation and interleukin-12 production by complement iC3b via a mitogen-activated protein kinase signalling pathway. Exp. Dermatol. 2005, 14:303-310.
43. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L., Kukutsch N.A., Rossner S., Schuler G., Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 2000, 30:1813-1822.
44. Mahnke K., Schmitt E., Bonifaz L., Enk A.H., Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 2002, 80:477-483.
45. Mehling A., Grabbe S., Voskort M., Schwarz T., Luger T.A., Beissert S. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J. Immunol. 2000, 165:2374-2381.
46. Mele T.S., Halloran P.F. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000, 47:215-245.
47. + T cells. J. Leukoc. Biol. 2008, 84:460-467.
48. Nakagawa S., Ohtani T., Mizuashi M., Mollah Z.U., Ito Y., Tagami H., Aiba S. p38 Mitogen-Activated protein kinase mediates dual role of ultraviolet B radiation in induction of maturation and apoptosis of monocyte-derived dendritic cells. J. Invest. Dermatol. 2004, 123:361-370.
49. Nakahara T., Uchi H., Urabe K., Chen Q., Furue M., Moroi Y. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. Int. Immunol. 2004, 16:1701-1709.
50. Neves B.M., Cruz M.T., Francisco V., Garcia-Rodriguez C., Silvestre R., Cordeiro-da-Silva A., Dinis A.M., Batista M.T., Duarte C.B., Lopes M.C. Differential roles of PI3-Kinase. MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile. Mol. Immunol. 2009, 46:2481-2492.
51. - T cells. Int. Immunol. 2004, 16:1203-1213.
52. Park J., Ha H., Seo J., Kim M.S., Kim H.J., Huh K.H., Park K., Kim Y.S. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Am. J. Transplant 2004, 4:1982-1990.
53. Puig-Kroger A., Relloso M., Fernandez-Capetillo O., Zubiaga A., Silva A., Bernabeu C., Corbi A.L. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 2001, 98:2175-2182.
54. Pulendran B., Kumar P., Cutler C.W., Mohamadzadeh M., Van Dyke T., Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 2001, 167:5067-5076.
55. Rescigno M., Martino M., Sutherland C.L., Gold M.R., Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 1998, 188:2175-2180.
56. Rincon M., Enslen H., Raingeaud J., Recht M., Zapton T., Su M.S., Penix L.A., Davis R.J., Flavell R.A. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 1998, 17:2817-2829.
57. Rossi M., Young J.W. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 2005, 175:1373-1381.
58. Sato K., Nagayama H., Tadokoro K., Juji T., Takahashi T.A. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J. Immunol. 1999, 162:3865-3872.
59. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 2004, 75:163-189.
60. Sintchak M.D., Fleming M.A., Futer O., Raybuck S.A., Chambers S.P., Caron P.R., Murcko M.A., Wilson K.P. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell 1996, 85:921-930.
61. Sollinger H.W., Belzer F.O., Deierhoi M.H., Diethelm A.G., Gonwa T.A., Kauffman R.S., Klintmalm G.B., McDiarmid S.V., Roberts J., Rosenthal J.T., et al. RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann. Surg. 1992, 216:513-518. (discussion 518-9).
62. Song A.T., Abdala E., Bonazzi P.R., Bacchella T., Machado M.C. Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?-a mini-review. Braz. J. Infect. Dis. 2006, 10:132-138.
63. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
64. Thornley T.B., Phillips N.E., Beaudette-Zlatanova B.C., Markees T.G., Bahl K., Brehm M.A., Shultz L.D., Kurt-Jones E.A., Mordes J.P., Welsh R.M., Rossini A.A., Greiner D.L. Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance. J. Immunol. 2007, 179:6620-6629.
65. Tiefenthaler M., Hofer S., Ebner S., Ivarsson L., Neyer S., Herold M., Mayer G., Fritsch P., Heufler C. In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. Nephrol. Dial. Transplant 2004, 19:553-560.
66. Zaru R., Ronkina N., Gaestel M., Arthur J.S., Watts C. The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat. Immunol. 2007, 8:1227-1235.
67. - cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 2004, 172:5213-5221.
68. Zhou L.F., Zhang M.S., Yin K.S., Ji Y., Xie W.P., Cui X.F., Ji X.H. Effects of adenoviral gene transfer of mutated IkappaBalpha, a novel inhibitor of NF-kappaB, on human monocyte-derived dendritic cells. Acta Pharmacol. Sin. 2006, 27:609-616.